Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

321

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

January 30, 2025

Study Completion Date

January 30, 2025

Conditions
Post-COVID-19 Syndrome
Interventions
DRUG

Prednisolone 20 mg/ 5 mg

Administration of prednisolone 20 mg for 5 days, followed by prednisolone 5 mg for 23 days.

DRUG

Vitamin B compound (100mg B1, 50 mg B6, 500 µg B12)

Administration of vitamin B compound for 28 days.

DRUG

Placebo for Vitamin B compound

Administration of placebo for vitamin B compound placebo for 28 days.

DRUG

Placebo for Prednisolon

Administration of placebo for prednisolone 20 mg for 5 days, followed by placebo for prednisolone 5 mg for 23 days.

Trial Locations (3)

97080

University Hospital Wuerzburg, Würzburg

Unknown

Unversity Hospital Schleswig-Holstein, Kiel

University Hospital Tuebingen, Tübingen

All Listed Sponsors
collaborator

University Hospital Tuebingen

OTHER

collaborator

University Hospital Schleswig-Holstein

OTHER

lead

Wuerzburg University Hospital

OTHER